Telix Pharmaceuticals Limited (ASX: TLX)
Australia
· Delayed Price · Currency is AUD 22.20
-0.76 (-3.31%)
Nov 21, 2024, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 7.43 billion as of November 21, 2024. Its market cap has increased by 140.60% in one year.
Market Cap
7.43B
Enterprise Value
7.33B
Revenue
645.68M
Ranking
n/a
PE Ratio
150.93
Stock Price
22.20
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 7.43B, an increase of 4,787.27%. That is a compound annual growth rate of 74.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 132.82B |
| ResMed Inc. | 53.57B |
| Pro Medicus Limited | 22.43B |
| Fisher & Paykel Healthcare Corporation Limited | 19.67B |
| Cochlear Limited | 19.50B |
| Sonic Healthcare Limited | 13.34B |
| Ramsay Health Care Limited | 8.73B |
| Clarity Pharmaceuticals Ltd | 1.94B |